Effects of prolonged treatment with 25-hydroxycholecalciferol in hypophosphatemic (vitamin D refractory) rickets and osteomalacia.
D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001827:Body Height; D001835:Body Weight; D002118:Calcium / Q000097:blood / Q000652:urine; D002675:Child, Preschool; D002762:Cholecalciferol / Q000627:therapeutic use*; D004872:Ergocalciferols / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006909:Hydroxyproline / Q000652:urine; D007015:Hypophosphatemia, Familial / Q000097:blood / Q000150:complications / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000201:enzymology / Q000652:urine; D008297:Male; D010018:Osteomalacia / Q000097:blood / Q000150:complications / Q000188:drug therapy* / Q000652:urine; D010710:Phosphates / Q000627:therapeutic use; D010758:Phosphorus / Q000097:blood; D011859:Radiography; D014953:Wrist / Q000000981:diagnostic imaging
D004872:Ergocalciferols; D010710:Phosphates; D002762:Cholecalciferol; D010758:Phosphorus; D000469:Alkaline Phosphatase; D006909:Hydroxyproline; D002118:Calcium